Analyze Diet
BMC genomics2014; 15(1); 947; doi: 10.1186/1471-2164-15-947

Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis.

Abstract: Osteochondrosis (OC(D)) is a juvenile osteo-articular disorder affecting several mammalian species. In horses, OC(D) is considered as a multifactorial disease and has been described as a focal disruption of endochondral ossification leading to the development of osteoarticular lesions. Nevertheless, OC(D) physiopathology is poorly understood. Affected horses may present joint swelling, stiffness and lameness. Thus, OC(D) is a major concern for the equine industry. Our study was designed as an integrative approach using omics technologies for the identification of constitutive defects in epiphyseal cartilage and/or subchondral bone associated with the development of primary lesions to further understand OC(D) pathology. This study compared samples from non-affected joints (hence lesion-free) from OC(D)-affected foals (n = 5, considered predisposed samples) with samples from OC-free foals (n = 5) considered as control samples. Consequently, results are not confounded by changes associated with the evolution of the lesion, but focus on altered constitutive molecular mechanisms. Comparative proteomics and micro computed tomography analyses were performed on predisposed and OC-free bone and cartilage samples. Metabolomics was also performed on synovial fluid from OC-free, OC(D)-affected and predisposed joints. Results: Two lesion subtypes were identified: OCD (lesion with fragment) and OC (osteochondral defects). Modulated proteins were identified using omics technologies (2-DE proteomics) in cartilage and bone from affected foals compare to OC-free foals. These were associated with cellular processes including cell cycle, energy production, cell signaling and adhesion as well as tissue-specific processes such as chondrocyte maturation, extracellular matrix and mineral metabolism. Of these, five had already been identified in synovial fluid of OC-affected foals: ACTG1 (actin, gamma 1), albumin, haptoglobin, FBG (fibrinogen beta chain) and C4BPA (complement component 4 binding protein, alpha). Conclusions: This study suggests that OCD lesions may result from a cartilage defect whereas OC lesions may be triggered by both bone and cartilage defects, suggesting that different molecular mechanisms responsible for the equine osteochondrosis lesion subtypes and predisposition could be due to a defect in both bone and cartilage. This study will contribute to refining the definition of OC(D) lesions and may improve diagnosis and development of therapies for horses and other species, including humans.
Publication Date: 2014-10-31 PubMed ID: 25359417PubMed Central: PMC4233069DOI: 10.1186/1471-2164-15-947Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses how the use of omics technologies have increased understanding of equine osteochondrosis. It progresses to explain how these technologies were used to identify altered molecular mechanisms within bone and cartilage that could potentially lead to the development of the disease.

Research Objective

  • The study aimed to identify the elements in bone and cartilage that could potentially lead to the onset of equine osteochondrosis (OC(D)), a juvenile osteo-articular disorder that affects horses. The disorder is a significant concern for horse breeders and owners because it can lead to joint stiffness, limb lameness, and swelling.

Methodology

  • The study compared the joints of foals displaying OC(D) symptoms with those of foal samples not affected by the disease. To do this, the researchers used omics technologies to study and compare the samples. Omics technologies refer to the different types of biological analysis approaches in genomics, proteomics, metabolomics and others that seek comprehensive and holistic views of the structures, functions, and dynamics of an organism or populations of organisms.
  • These comparisons were done in a way that did not factor in changes associated with the evolution of the lesion but focused on altered molecular mechanisms that might have led to the onset of the disease.
  • They performed comparative proteomics and micro computed tomography analyses on healthy and predisposed bone and cartilage samples. They also performed metabolomics on synovial fluid, which is a viscous liquid found in small quantities in the cavities of the synovial joints.

Results

  • Through their research, the team turned up two OC(D) subtypes: Osteochondrosis dissecans (OCD) – which left a lesion with fragment- and osteochondral defects (OC), through the use of omics technologies they were also able to identify proteins that were modulated in cartilage and bone samples from foals affected by OC(D) in comparison to samples not affected by the disease.
  • They established that the modulated proteins were associated with cellular processes including energy production, cell signalling, cell cycle, tissue-specific processes such as mineral metabolism, extracellular matrix and chondrocyte maturation.
  • Furthermore, five of these proteins, which included fibrinogen beta chain (FBG), albumin, actin, gamma 1 (ACTG1), complement component 4 binding protein, alpha (C4BPA), and haptoglobin, had already been identified in synovial fluid of OC(D)-affected foals.

Conclusions

  • The study suggested that OC(D) lesions likely result from a defect in cartilage or bone, and that different molecular mechanisms could be responsible for the specific types of equine osteochondrosis lesions found.
  • The researchers believe this study will help improve the definition of OC(D) lesions and potentially contribute to the development of therapeutic solutions to treat the disorder in horses and possibly even humans.

Cite This Article

APA
Desjardin C, Riviere J, Vaiman A, Morgenthaler C, Diribarne M, Zivy M, Robert C, Le Moyec L, Wimel L, Lepage O, Jacques C, Cribiu E, Schibler L. (2014). Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis. BMC Genomics, 15(1), 947. https://doi.org/10.1186/1471-2164-15-947

Publication

ISSN: 1471-2164
NlmUniqueID: 100965258
Country: England
Language: English
Volume: 15
Issue: 1
Pages: 947
PII: 947

Researcher Affiliations

Desjardin, Clémence
    Riviere, Julie
      Vaiman, Anne
        Morgenthaler, Caroline
          Diribarne, Mathieu
            Zivy, Michel
              Robert, Céline
                Le Moyec, Laurence
                  Wimel, Laurence
                    Lepage, Olivier
                      Jacques, Claire
                        Cribiu, Edmond
                          Schibler, Laurent
                          • INRA, UMR1313, Biologie Intégrative et Génétique Animale, Jouy-en-Josas, France. laurent.schibler@unceia.fr.

                          MeSH Terms

                          • Animals
                          • Growth Plate / diagnostic imaging
                          • Growth Plate / metabolism
                          • Growth Plate / pathology
                          • Horse Diseases / metabolism
                          • Horse Diseases / pathology
                          • Horses
                          • Joints / pathology
                          • Metabolic Networks and Pathways
                          • Osteochondrosis / metabolism
                          • Osteochondrosis / pathology
                          • Osteochondrosis / veterinary
                          • Proteomics
                          • X-Ray Microtomography

                          References

                          This article includes 51 references
                          1. Olsson SE. Osteochondrosis in domestic animals. Introduction.. Acta Radiol Suppl 1978;358:9-14.
                            pubmed: 233603
                          2. McIlwraith CW. Osteochondrosis. In: Baxter GM, editor. Adams and Stashak’s Lameness in Horses. 6. 2011. pp. 1155–1164.
                          3. Jeffcott LB, Henson FM. Studies on growth cartilage in the horse and their application to aetiopathogenesis of dyschondroplasia (osteochondrosis).. Vet J 1998 Nov;156(3):177-92.
                            doi: 10.1016/S1090-0233(98)80121-4pubmed: 9883086google scholar: lookup
                          4. Ytrehus B, Carlson CS, Ekman S. Etiology and pathogenesis of osteochondrosis.. Vet Pathol 2007 Jul;44(4):429-48.
                            doi: 10.1354/vp.44-4-429pubmed: 17606505google scholar: lookup
                          5. Lepeule J, Bareille N, Robert C, Ezanno P, Valette JP, Jacquet S, Blanchard G, Denoix JM, Seegers H. Association of growth, feeding practices and exercise conditions with the prevalence of Developmental Orthopaedic Disease in limbs of French foals at weaning.. Prev Vet Med 2009 Jun 1;89(3-4):167-77.
                          6. McIlwraith CW. Developmental orthopedic disease: problems of limbs in young horses. J Equine Vet Sci 2004;24:475–479.
                          7. Jeffcott LB. Osteochondrosis in the horse--searching for the key to pathogenesis.. Equine Vet J 1991 Sep;23(5):331-8.
                          8. Distl O. The genetics of equine osteochondrosis.. Vet J 2013 Jul;197(1):13-8.
                            doi: 10.1016/j.tvjl.2013.03.036pubmed: 23809989google scholar: lookup
                          9. van Weeren PR, Jeffcott LB. Problems and pointers in osteochondrosis: Twenty years on.. Vet J 2013 Jul;197(1):96-102.
                            doi: 10.1016/j.tvjl.2013.03.048pubmed: 23639371google scholar: lookup
                          10. Olstad K, Ytrehus B, Ekman S, Carlson CS, Dolvik NI. Epiphyseal cartilage canal blood supply to the distal femur of foals.. Equine Vet J 2008 Jul;40(5):433-9.
                            doi: 10.2746/042516408X300269pubmed: 18487109google scholar: lookup
                          11. Ytrehus B, Ekman S, Carlson CS, Teige J, Reinholt FP. Focal changes in blood supply during normal epiphyseal growth are central in the pathogenesis of osteochondrosis in pigs.. Bone 2004 Dec;35(6):1294-306.
                            doi: 10.1016/j.bone.2004.08.016pubmed: 15589210google scholar: lookup
                          12. Henson FM, Davies ME, Jeffcott LB. Equine dyschondroplasia (osteochondrosis)--histological findings and type VI collagen localization.. Vet J 1997 Jul;154(1):53-62.
                            doi: 10.1016/S1090-0233(05)80008-5pubmed: 9265853google scholar: lookup
                          13. Denoix JM, Jeffcott LB, McIlwraith CW, van Weeren PR. A review of terminology for equine juvenile osteochondral conditions (JOCC) based on anatomical and functional considerations.. Vet J 2013 Jul;197(1):29-35.
                            doi: 10.1016/j.tvjl.2013.03.038pubmed: 23683533google scholar: lookup
                          14. Olstad K, Ytrehus B, Ekman S, Carlson CS, Dolvik NI. Early lesions of osteochondrosis in the distal tibia of foals.. J Orthop Res 2007 Aug;25(8):1094-105.
                            doi: 10.1002/jor.20375pubmed: 17415757google scholar: lookup
                          15. Muir H. The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules.. Bioessays 1995 Dec;17(12):1039-48.
                            doi: 10.1002/bies.950171208pubmed: 8634065google scholar: lookup
                          16. Guilak F, Fermor B, Keefe FJ, Kraus VB, Olson SA, Pisetsky DS, Setton LA, Weinberg JB. The role of biomechanics and inflammation in cartilage injury and repair.. Clin Orthop Relat Res 2004 Jun;(423):17-26.
                          17. Dik KJ, Enzerink E, van Weeren PR. Radiographic development of osteochondral abnormalities, in the hock and stifle of Dutch Warmblood foals, from age 1 to 11 months.. Equine Vet J Suppl 1999 Nov;(31):9-15.
                          18. Desjardin C, Balliau T, Valot B, Zivy M, Wimel L, Guérin G, Cribiu E, Schibler L. A method for proteomic analysis of equine subchondral bone and epiphyseal cartilage.. Proteomics 2012 Jun;12(11):1870-4.
                            doi: 10.1002/pmic.201100366pubmed: 22623359google scholar: lookup
                          19. Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics.. Anal Chem 2006 Jul 1;78(13):4281-90.
                            doi: 10.1021/ac051632cpubmed: 16808434google scholar: lookup
                          20. Chiaradia E, Pepe M, Tartaglia M, Scoppetta F, D'Ambrosio C, Renzone G, Avellini L, Moriconi F, Gaiti A, Bertuglia A, Beccati F, Scaloni A. Gambling on putative biomarkers of osteoarthritis and osteochondrosis by equine synovial fluid proteomics.. J Proteomics 2012 Jul 19;75(14):4478-93.
                            doi: 10.1016/j.jprot.2012.02.008pubmed: 22361695google scholar: lookup
                          21. Schenck RC Jr, Goodnight JM. Osteochondritis dissecans.. J Bone Joint Surg Am 1996 Mar;78(3):439-56.
                            pubmed: 8613454
                          22. Siffert RS. Classification of the osteochondroses.. Clin Orthop Relat Res 1981 Jul-Aug;(158):10-8.
                            pubmed: 7273506
                          23. Sandell LJ, Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis.. Arthritis Res 2001;3(2):107-13.
                            doi: 10.1186/ar148pmc: PMC128887pubmed: 11178118google scholar: lookup
                          24. Gee E, Davies M, Firth E, Jeffcott L, Fennessy P, Mogg T. Osteochondrosis and copper: histology of articular cartilage from foals out of copper supplemented and non-supplemented dams.. Vet J 2007 Jan;173(1):109-17.
                            doi: 10.1016/j.tvjl.2005.09.015pubmed: 16314126google scholar: lookup
                          25. Donabedian M, Fleurance G, Perona G, Robert C, Lepage O, Trillaud-Geyl C, Leger S, Ricard A, Bergero D, Martin-Rosset W. Effect of fast vs. moderate growth rate related to nutrient intake on developmental orthopaedic disease in the horse. Anim Res 2006;55:471–486.
                            doi: 10.1051/animres:2006026google scholar: lookup
                          26. Hilla D, Distl O. Heritabilities and genetic correlations between fetlock, hock and stifle osteochondrosis and fetlock osteochondral fragments in Hanoverian Warmblood horses.. J Anim Breed Genet 2014 Feb;131(1):71-81.
                            doi: 10.1111/jbg.12062pubmed: 24236645google scholar: lookup
                          27. Ricard A, Perrocheau M, Couroucé-Malblanc A, Valette JP, Tourtoulou G, Dufosset JM, Robert C, Chaffaux S, Denoix JM, Guérin G. Genetic parameters of juvenile osteochondral conditions (JOCC) in French Trotters.. Vet J 2013 Jul;197(1):77-82.
                            doi: 10.1016/j.tvjl.2013.03.045pubmed: 23639370google scholar: lookup
                          28. Lykkjen S, Olsen HF, Dolvik NI, Grøndahl AM, Røed KH, Klemetsdal G. Heritability estimates of tarsocrural osteochondrosis and palmar/plantar first phalanx osteochondral fragments in Standardbred trotters.. Equine Vet J 2014 Jan;46(1):32-7.
                            doi: 10.1111/evj.12058pubmed: 23448227google scholar: lookup
                          29. Teyssèdre S, Dupuis MC, Guérin G, Schibler L, Denoix JM, Elsen JM, Ricard A. Genome-wide association studies for osteochondrosis in French Trotter horses.. J Anim Sci 2012 Jan;90(1):45-53.
                            doi: 10.2527/jas.2011-4031pubmed: 21841084google scholar: lookup
                          30. Alexopoulos LG, Youn I, Bonaldo P, Guilak F. Developmental and osteoarthritic changes in Col6a1-knockout mice: biomechanics of type VI collagen in the cartilage pericellular matrix.. Arthritis Rheum 2009 Mar;60(3):771-9.
                            doi: 10.1002/art.24293pmc: PMC2724839pubmed: 19248115google scholar: lookup
                          31. Connor JR, Kumar S, Sathe G, Mooney J, O'Brien SP, Mui P, Murdock PR, Gowen M, Lark MW. Clusterin expression in adult human normal and osteoarthritic articular cartilage.. Osteoarthritis Cartilage 2001 Nov;9(8):727-37.
                            doi: 10.1053/joca.2001.0475pubmed: 11795992google scholar: lookup
                          32. Hobson GM, Funanage VL, Elsemore J, Yagami M, Rajpurohit R, Perriard JC, Hickok NJ, Shapiro IM, Tuan RS. Developmental expression of creatine kinase isoenzymes in chicken growth cartilage.. J Bone Miner Res 1999 May;14(5):747-56.
                            doi: 10.1359/jbmr.1999.14.5.747pubmed: 10320523google scholar: lookup
                          33. Skagen PS, Horn T, Kruse HA, Staergaard B, Rapport MM, Nicolaisen T. Osteochondritis dissecans (OCD), an endoplasmic reticulum storage disease?: a morphological and molecular study of OCD fragments.. Scand J Med Sci Sports 2011 Dec;21(6):e17-33.
                          34. Wang X, Eno CO, Altman BJ, Zhu Y, Zhao G, Olberding KE, Rathmell JC, Li C. ER stress modulates cellular metabolism.. Biochem J 2011 Apr 1;435(1):285-96.
                            doi: 10.1042/BJ20101864pmc: PMC3072169pubmed: 21241252google scholar: lookup
                          35. Naughton D, Whelan M, Smith EC, Williams R, Blake DR, Grootveld M. An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy.. FEBS Lett 1993 Feb 8;317(1-2):135-8.
                            doi: 10.1016/0014-5793(93)81508-Wpubmed: 8381364google scholar: lookup
                          36. Desjardin C, Chat S, Gilles M, Legendre R, Riviere J, Mata X, Balliau T, Esquerré D, Cribiu EP, Betch JM, Schibler L. Involvement of mitochondrial dysfunction and ER-stress in the physiopathology of equine osteochondritis dissecans (OCD).. Exp Mol Pathol 2014 Jun;96(3):328-38.
                            doi: 10.1016/j.yexmp.2014.03.004pubmed: 24657499google scholar: lookup
                          37. Xu L, Flahiff CM, Waldman BA, Wu D, Olsen BR, Setton LA, Li Y. Osteoarthritis-like changes and decreased mechanical function of articular cartilage in the joints of mice with the chondrodysplasia gene (cho).. Arthritis Rheum 2003 Sep;48(9):2509-18.
                            doi: 10.1002/art.11233pubmed: 13130470google scholar: lookup
                          38. Yoshimi M, Miyaishi O, Nakamura S, Shirasawa S, Kamochi H, Miyatani S, Ikawa Y, Shinomura T. Identification of genes preferentially expressed in articular cartilage by suppression subtractive hybridization.. J Med Dent Sci 2005 Dec;52(4):203-11.
                            pubmed: 16669454
                          39. Seto J, Busse B, Gupta HS, Schäfer C, Krauss S, Dunlop JW, Masic A, Kerschnitzki M, Zaslansky P, Boesecke P, Catalá-Lehnen P, Schinke T, Fratzl P, Jahnen-Dechent W. Accelerated growth plate mineralization and foreshortened proximal limb bones in fetuin-A knockout mice.. PLoS One 2012;7(10):e47338.
                          40. Woods A, Wang G, Beier F. Regulation of chondrocyte differentiation by the actin cytoskeleton and adhesive interactions.. J Cell Physiol 2007 Oct;213(1):1-8.
                            doi: 10.1002/jcp.21110pubmed: 17492773google scholar: lookup
                          41. Luegmayr E, Glantschnig H, Wesolowski GA, Gentile MA, Fisher JE, Rodan GA, Reszka AA. Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins.. Cell Death Differ 2004 Jul;11 Suppl 1:S108-18.
                            doi: 10.1038/sj.cdd.4401399pubmed: 15017384google scholar: lookup
                          42. Ackert-Bicknell CL. HDL cholesterol and bone mineral density: is there a genetic link?. Bone 2012 Feb;50(2):525-33.
                            doi: 10.1016/j.bone.2011.07.002pmc: PMC3236254pubmed: 21810493google scholar: lookup
                          43. Gohda T, Makita Y, Shike T, Tanimoto M, Funabiki K, Horikoshi S, Tomino Y. Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a Type 2 diabetes model: is Zn-alpha2 glycoprotein-1 a candidate gene for obesity?. Diabetes 2003 Aug;52(8):2175-81.
                            doi: 10.2337/diabetes.52.8.2175pubmed: 12882938google scholar: lookup
                          44. Zhang B, Guo YK, Li S, Zhang LZ, Lan XY, Hu SR, Chen H. Genotype and haplotype analysis of the AZGP1 gene in cattle.. Mol Biol Rep 2012 Dec;39(12):10475-9.
                            doi: 10.1007/s11033-012-1928-xpubmed: 23073769google scholar: lookup
                          45. Rousselle AV, Heymann D. Osteoclastic acidification pathways during bone resorption.. Bone 2002 Apr;30(4):533-40.
                            doi: 10.1016/S8756-3282(02)00672-5pubmed: 11934642google scholar: lookup
                          46. Orriss IR, Knight GE, Ranasinghe S, Burnstock G, Arnett TR. Osteoblast responses to nucleotides increase during differentiation.. Bone 2006 Aug;39(2):300-9.
                            doi: 10.1016/j.bone.2006.02.063pubmed: 16616882google scholar: lookup
                          47. Sömjen D, Kaye AM, Binderman I. Stimulation of creatine kinase BB activity by parathyroid hormone and by prostaglandin E2 in cultured bone cells.. Biochem J 1985 Feb 1;225(3):591-6.
                            pmc: PMC1144633pubmed: 3856427doi: 10.1042/bj2250591google scholar: lookup
                          48. Chang X, Zheng Y, Yang Q, Wang L, Pan J, Xia Y, Yan X, Han J. Carbonic anhydrase I (CA1) is involved in the process of bone formation and is susceptible to ankylosing spondylitis.. Arthritis Res Ther 2012 Jul 27;14(4):R176.
                            doi: 10.1186/ar3929pmc: PMC3580570pubmed: 22838845google scholar: lookup
                          49. Madry H, van Dijk CN, Mueller-Gerbl M. The basic science of the subchondral bone.. Knee Surg Sports Traumatol Arthrosc 2010 Apr;18(4):419-33.
                            doi: 10.1007/s00167-010-1054-zpubmed: 20119671google scholar: lookup
                          50. Hügle T, Kovacs H, Heijnen IA, Daikeler T, Baisch U, Hicks JM, Valderrabano V. Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy.. Clin Exp Rheumatol 2012 Mar-Apr;30(2):240-5.
                            pubmed: 22410098
                          51. Lacitignola L, Fanizzi FP, Francioso E, Crovace A. 1H NMR investigation of normal and osteo-arthritic synovial fluid in the horse.. Vet Comp Orthop Traumatol 2008;21(1):85-8.
                            pubmed: 18288348doi: 10.3415/vcot-06-12-0101google scholar: lookup

                          Citations

                          This article has been cited 3 times.
                          1. Tran H, McConville M, Loukopoulos P. Metabolomics in the study of spontaneous animal diseases. J Vet Diagn Invest 2020 Sep;32(5):635-647.
                            doi: 10.1177/1040638720948505pubmed: 32807042google scholar: lookup
                          2. Chiaradia E, Pepe M, Orvietani PL, Renzone G, Magini A, Sforna M, Emiliani C, Di Meo A, Scaloni A. Proteome Alterations in Equine Osteochondrotic Chondrocytes. Int J Mol Sci 2019 Dec 7;20(24).
                            doi: 10.3390/ijms20246179pubmed: 31817880google scholar: lookup
                          3. Laus F, Gialletti R, Bazzano M, Laghi L, Dini F, Marchegiani A. Synovial Fluid Metabolome Can Differentiate between Healthy Joints and Joints Affected by Osteoarthritis in Horses. Metabolites 2023 Aug 4;13(8).
                            doi: 10.3390/metabo13080913pubmed: 37623857google scholar: lookup